Coave has raised €32m ($33m) in a Series A financing round for advancing its Advanced Vectors-Ligand Conjugates (ALIGATER) platform.

The potential of using artificial intelligence in drug discovery and development has sparked both excitement and ...

Indaptus Therapeutics, Inc. (Nasdaq: INDP) ("Indaptus" or the "Company"), a clinical-stage biotechnology company pioneering innovative cancer and viral infection ...

Dr. Artem Cherkasov remarked, “With these newly synthesized drug candidates identified and now advancing into testing, Rakovina Therapeutics is delivering on its promise of innovation. This ...

Researchers have applied AI and machine learning to every stage of the drug development process. This includes identifying targets in the body, screening potential candidates, designing drug molecules ...

Insilico Medicine ('Insilico'), a clinical-stage generative artificial intelligence (AI)-driven drug discovery and development company, today announced the nomination of ISM1745, a potentially best-in ...

Invenra has launched its Rapid Antibody Discovery Service, designed to simplify and de-risk the preclinical development of ...

The blood-brain barrier (BBB) is a major hurdle for the development of systemically delivered drugs targeting diseases of the central nervous system (CNS). Because of this barrier there is a huge ...

Veeda Group has unveiled a new logo and brand identity--Veeda Lifesciences--marking a key milestone in its journey. The new ...

Insilico Medicine (‘Insilico’), a clinical-stage generative artificial intelligence (AI)-driven drug discovery and ...

Adults working with pre-school children need to have a knowledge of child development and what is expected at each level of development, for example approximately what age babies start to walk, talk ...